Contracting Out Gives Laboratories An In With Diagnostics Manufacturers
This article was originally published in The Gray Sheet
Executive Summary
Manufacturers and laboratories have until September to begin complying with FDA's analyte specific reagent policy, clarified in 2007 guidelines. But some labs, particularly those specializing in molecular diagnostics, are scrambling to fill what could be a gap in needed supplies
You may also be interested in...
Test Makers Have One Year To Comply With New ASR Guidelines
Diagnostic test makers will have until September 2008 to comply with newly clarified FDA policies for analyte specific reagents
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.